BCM
HALO icon

Bridgeway Capital Management’s Halozyme HALO Stock Holding History

Bridgeway Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42,800
Closed -$1.54M – 1393
2023
Q2 		$1.54M Hold
42,800
– – 0.04% 620
2023
Q1 		$1.63M Hold
42,800
– – 0.04% 598
2022
Q4 		$2.44M Hold
42,800
– – 0.06% 491
2022
Q3 		$1.69M Buy
+42,800
New +$1.89M 0.05% 580

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bridgeway Capital Management's HALO Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Halozyme (HALO) in Q3 2023, closing a stake of 42,800 shares — an estimated $1.54M sold.

Bridgeway Capital Management first reported a position in HALO in Q3 2022 and held it in 4 quarters. The position peaked at $2.44M in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 42,800 Halozyme shares in Q3 2023, an estimated $1.54M.
  • Bridgeway Capital Management first reported a position in Halozyme in Q3 2022 and held it in 4 quarters.
  • Bridgeway Capital Management's Halozyme position peaked at $2.44M in Q4 2022.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.